Subscribe to our newsletter and stay informed

Check out our list of top companies

Check out our carefully compiled lists of the most relevant and impactful companies within their fields.

Check out our list of top unicorns

Read and learn about the biggest companies that various countries have produced, how they made it, and what the future looks like for them.

Nettle: Women's Health Revolution by Samphire

UK medtech startup Samphire Neuroscience unveils a "science-backed" solution to age-old women's health challenges
February 22, 2024

For many women, the monthly experience of menstrual pain and mood swings is an unavoidable reality, often managed with painkillers or hormonal treatments. However, UK-based medtech startup Samphire Neuroscience is challenging this status quo with a groundbreaking approach to women's health. By harnessing the power of neuromodulation, their wearable device aims to provide drug-free relief from menstrual pain and mood disorders, offering hope to millions of women worldwide.

Samphire Neuroscience's wearable device, named Nettle, utilizes transcranial direct current stimulation (tDCS) to target regions of the brain associated with pain perception and mood regulation. Unlike traditional treatments that rely on medication or invasive procedures, Nettle offers a non-invasive and science-backed alternative for managing period pain and premenstrual syndrome (PMS). By applying a low electrical current, Nettle aims to reduce pain sensitivity and block pain signals, providing a holistic approach to women's health.

tDCS works by increasing neuroplasticity, the brain's ability to adapt and reorganize synaptic connections. In the context of women's health, hormonal fluctuations during the menstrual cycle can impact brain structure and activity, influencing mood, energy levels, and sensitivity. By targeting specific brain regions associated with menstrual pain and PMS, Nettle seeks to alleviate symptoms and improve overall well-being.

What sets Samphire's solution apart is its dual focus on addressing both physical and psychological symptoms. By stimulating brain regions involved in pain perception and mood regulation, Nettle offers a comprehensive treatment approach tailored to women's unique needs. Early results have shown significant pain reduction during menstrual periods, underscoring the potential of neuromodulation as a game-changer in women's healthcare.

Samphire Neuroscience's innovative approach to women's health represents a paradigm shift in how we understand and manage menstrual pain and mood disorders. By harnessing the power of neuromodulation, Nettle offers a drug-free and effective solution that holds promise for millions of women worldwide. As the company continues to advance its research and development efforts, the future of women's healthcare looks brighter than ever before.

More about: 

Last related articles

chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram